These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 15973769

  • 1. Character of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M mutation in patients with lamivudine resistance.
    Li MW, Hou W, Wo JE, Liu KZ.
    J Zhejiang Univ Sci B; 2005 Jul; 6(7):664-7. PubMed ID: 15973769
    [Abstract] [Full Text] [Related]

  • 2. [Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].
    Cao XX, Li J, Qiu LM, Luo YW, Chen YH, Ran Y.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):641-4. PubMed ID: 19785947
    [Abstract] [Full Text] [Related]

  • 3. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.
    J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region.
    Natsuizaka M, Hige S, Ono Y, Ogawa K, Nakanishi M, Chuma M, Yoshida S, Asaka M.
    J Viral Hepat; 2005 Mar; 12(2):154-9. PubMed ID: 15720530
    [Abstract] [Full Text] [Related]

  • 5. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F, Vincenti D, Vairo F, Solmone M, Mariano A, Piselli P, Puro V, Capobianchi MR, Antonucci G.
    J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
    [Abstract] [Full Text] [Related]

  • 6. [Mutations of HBV polymerase gene sequence in lamivudine-resistant chronic hepatitis B patients].
    Wang C, Sun J, Chen JJ, Wang ZH, Hou JL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):729-30. PubMed ID: 18504191
    [Abstract] [Full Text] [Related]

  • 7. [Types and emergence time of YMDD motif mutation in hepatitis B virus polymerase gene during lamivudine treatment].
    Liang WF, Yang DH, Shen YH, Xie YJ, Zhao NF.
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):302-4. PubMed ID: 12773248
    [Abstract] [Full Text] [Related]

  • 8. Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
    Audsley J, Arrifin N, Yuen LK, Ayres A, Crowe SM, Bartholomeusz A, Locarnini SA, Mijch A, Lewin SR, Sasadeusz J.
    HIV Med; 2009 Apr; 10(4):229-35. PubMed ID: 19178592
    [Abstract] [Full Text] [Related]

  • 9. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K, Takehara T, Kato M, Deguchi M, Kagita M, Hikita H, Sasakawa A, Kohga K, Uemura A, Sakamori R, Yamaguchi S, Miyagi T, Ishida H, Tatsumi T, Hayashi N.
    J Infect Dis; 2008 Oct 15; 198(8):1150-8. PubMed ID: 18713056
    [Abstract] [Full Text] [Related]

  • 10. Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy in human immunodeficiency virus coinfected patients: performance of CLIP sequencing and line probe assay.
    Roque-Afonso AM, Férey MP, Mackiewicz V, Fki L, Dussaix E.
    Antivir Ther; 2003 Dec 15; 8(6):627-34. PubMed ID: 14760897
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.
    Wakil SM, Kazim SN, Khan LA, Raisuddin S, Parvez MK, Guptan RC, Thakur V, Hasnain SE, Sarin SK.
    J Med Virol; 2002 Nov 15; 68(3):311-8. PubMed ID: 12226816
    [Abstract] [Full Text] [Related]

  • 12. [Detection of the mutation in HBV polymerase gene by RFLP PCR method in hepatitis B patients treated with lamivudine].
    Li Z, Guo YB, Hao W, Lin ZH, Jin HY, Liu DG.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep 15; 17(3):266-9. PubMed ID: 15340574
    [Abstract] [Full Text] [Related]

  • 13. Genotypic resistance of hepatitis B virus to lamivudine in renal transplant recipients.
    Joh JW, Lee HH, Park JW, Lee DH, Yoo BC, Lee KW, Kim SJ.
    Transplant Proc; 2005 Mar 15; 37(2):1235-7. PubMed ID: 15848680
    [Abstract] [Full Text] [Related]

  • 14. The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations.
    Zhu Y, Curtis M, Borroto-Esoda K.
    Antivir Chem Chemother; 2011 Aug 23; 22(1):13-22. PubMed ID: 21860069
    [Abstract] [Full Text] [Related]

  • 15. [Detection and analysis of the new kind of G743C and G743A point mutation of HBV P gene in hepatitis B virus infected patients resistant to lamivudine].
    Pan XP, Wo JE, Chen Z, Chen F, Liang WF, Liu KZ.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct 23; 11(10):616-8. PubMed ID: 14572341
    [Abstract] [Full Text] [Related]

  • 16. Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity.
    Ogata N, Ichida T, Aoyagi Y, Kitajima I.
    Rinsho Byori; 2003 Apr 23; 51(4):313-9. PubMed ID: 12747252
    [Abstract] [Full Text] [Related]

  • 17. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
    Selabe SG, Song E, Burnett RJ, Mphahlele MJ.
    J Med Virol; 2009 Jun 23; 81(6):996-1001. PubMed ID: 19382250
    [Abstract] [Full Text] [Related]

  • 18. YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine.
    Matsuda M, Suzuki F, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Satoh J, Kobayashi M, Ikeda K, Miyakawa Y, Kumada H.
    J Med Virol; 2004 Oct 23; 74(2):361-6. PubMed ID: 15332287
    [Abstract] [Full Text] [Related]

  • 19. Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler.
    Whalley SA, Brown D, Teo CG, Dusheiko GM, Saunders NA.
    J Clin Microbiol; 2001 Apr 23; 39(4):1456-9. PubMed ID: 11283071
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].
    Deng H, Lv Y, Fu J.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun 23; 12(6):368-9. PubMed ID: 15225437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.